Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1613 1722 1795 3785
This examiner grants 69% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18289733 | THERMOREVERSIBLE POLYMERS AND METHODS OF USE THEREOF | Non-Final OA | The Regents of the University of California |
| 17082929 | 5HT AGONISTS FOR TREATING DISORDERS | Non-Final OA | The Regents of the University of California |
| 19312633 | PERSONAL CARE PRODUCT COMPOSITIONS COMPRISING A FATTY AMIDE AND METHODS FOR MAKING SAME | Final Rejection | Ash Ingredients Inc. |
| 16771004 | STORAGE STABLE MIXTURES | Final Rejection | DSM IP ASSETS B.V. |
| 17786728 | ORAL TABLETS COMPRISING ROLLER-COMPACTED GRANULES OF NAPROXEN SODIUM, METHODS OF PREPARING THEREOF, AND METHODS OF USING THEREOF | Non-Final OA | Bayer HealthCare LLC |
| 18649602 | SUSPENSIONS OF RADIOPAQUE CROSSLINKED HYDROGEL PARTICLES IN CARRIER FLUIDS CONTAINING BIOCOMPATIBLE HYDROPHILIC POLYMERS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18313754 | BIODEGRADABLE POLYCAPROLACTONE CAPSULE FOR ANTIBODY RELEASE AND DEGRADATION | Non-Final OA | University Of Cincinnati |
| 17798336 | COSMETIC | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 18247508 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | Non-Final OA | KAO CORPORATION |
| 18552014 | FORMULATION COMPRISING CERALASERTIB | Final Rejection | ASTRAZENECA AB |
| 17201150 | DENTAL ADHESIVE COMPOSITION EXCELLENT IN STORAGE STABILITY | Final Rejection | SHOFU INC. |
| 18028675 | WATER-IN-OIL EMULSION COMPOSITION INCLUDING SALICYLIC ACID | Non-Final OA | Shiseido Company, Ltd. |
| 17909669 | LAMELLAR GEL-CONTAINING COMPOSITION, EMULSIFIED COMPOSITION, AND COMPOSITION FOR EXTERNAL-USE SKIN PREPARATION | Final Rejection | Shiseido Company, Ltd. |
| 18559736 | SQUEEZE FOAMER AND CONCENTRATES | Final Rejection | BEIERSDORF AG |
| 18439657 | Methods, Compositions and Devices Related to Seaweed Masks | Non-Final OA | Laclede, Inc. |
| 18014665 | METHODS OF ADMINISTERING TASTE MASKED PHENYLBUTYRATE AND COMPOSITIONS THEREFOR | Final Rejection | Acer Therapeutics Inc. |
| 18413411 | DISINFECTANT COMPOSITION FOR INFUSION INTO POROUS SURFACES AND THE METHOD OF PREPARATION THEREOF | Non-Final OA | EXPOSOME PVT. LTD. |
| 18410464 | NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES | Final Rejection | Nucleus Medical GmbH |
| 17839786 | NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES | Final Rejection | NUCLEUS MEDICAL GMBH |
| 18572983 | Method to Control Administration of Active Substance to the Digestive Tract | Non-Final OA | Lonza Greenwood LLC |
| 17633006 | TOPICAL FORMULATIONS COMPRISING CANNABIDIOL, METHOD OF PREPARING THE COMPOSITION AND USE THEREOF | Non-Final OA | CS Medica A/S |
| 17757801 | PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF | Non-Final OA | ASIERIS PHARMACEUTICALS (SHANGHAI) CO., LTD. |
| 17999923 | SUBSTANCE DELIVERY TO ANIMALS | Final Rejection | TG Medwise Ltd. |
| 18006061 | TOPICAL HEMOSTATIC POWDER COMPOSITION AND PREPARATION METHOD THEREFOR | Non-Final OA | THERACION BIOMEDICAL CO., LTD. |
| 17905145 | COMPOSITION FOR USE IN A TREATMENT OF CERVICAL CELL ABNORMALITIES COMPRISING SELENITE COMPOUND AND ACID | Final Rejection | SELO MEDICAL GMBH |
| 17617422 | SUSTAINED-RELEASE COMPOSITIONS OF ALPHA-KETOGLUTARATE | Non-Final OA | Ponce de Leon Health Designated Activity Company |
| 17435763 | COMPOSITIONS COMPRISING ALGAE POWDER AND USES THEREOF | Final Rejection | ALGATECHNOLOGIES LTD. |
| 17444829 | COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY | Final Rejection | Ziropa, Inc. |
| 16632843 | FORMULATION COMPRISING NANOSTRUCTURED, BIOCOMPATIBLE AND BIOCATALYTIC MATERIAL FOR THE TREATMENT OF WOUNDS AND INFECTIONS | Non-Final OA | Nanotess Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy